Nascent Pharma Holdings, Inc. (NASC)

OTCMKTS · Delayed Price · Currency is USD

0.0207

-0.0020 (-8.81%)

At close: Oct 28, 2025

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
Hemp Derived Products	1.34M	Log In	Log In	Log In	Log In	Upgrade
Hemp Derived Products Growth	-75.81%	Log In	Log In	Log In	Log In	Upgrade
Services	819.63K	Log In	Log In	Log In	Log In	Upgrade
Services Growth	-29.43%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
United States	2.16M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	-67.76%	Log In	Log In	Log In	Log In	Upgrade